20916 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Use of complement inhibitory proteins to treat spinal cord injury
#302Medicament and use thereof for tumor therapy
#303Compositions and methods for treatment of eye disorders
#304S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
#305Chimeric disintegrin domain
#306Compositions and methods for treating and preventing heart tissue degeneration and uses thereof
#307Cholinergic modulation of microglial activation via alpha-7 nicotinic receptors
#308Modified venom and venom components as anti-retroviral agents
#309Modified venom and venom components as anti-retroviral agents
#310Modified anticholinergic neurotoxins as modulators of the autoimmune reaction
#311Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis
#312Cosmetic or dermatological preparations having a content of anti-freezing proteins and/or anti-freezing glycoproteins
#313Protein binding miniature proteins and uses thereof
#314Cytomegalovirus disintegrin-like peptides
#315Process for controlling protein to salt ratio in animal muscle protein composition and protein composition
#316Modified venom and venom components as anti-retroviral agents
#317Synergistic antimicrobial compositions and methods for reducing biofilm formation
#318Combination therapy comprising a Cox-2 inhibitor and an antineoplastic agent
#319Copolymer-1 improvements in compositions of copolymers
#320Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction
#321Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof
#322Depilatories and agents for external use
#323Amino acids from fish and soy proteins improve insulin sensitivity
#324Morphogen-induced modulation of inflammatory response
#325Prospective identification and characterization of breast cancer stem cells
#326Methods and compositions for the treatment of motor neuron injury and neuropathy
#327Treatment of muscular dystrophies and related disorders
#328Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
#329Modified alpha-neurotoxins as painkillers
#330Methods for modulating hematopoiesis and vascular growth
#331Recombinant polypeptides and methods of use thereof